SavedAdd your journal

Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 23 - Sayı: 3

THE FACTORS ASSOCIATED WITH BLEEDING IN PATIENTS USING WARFARIN

Varfarin Kullanan Hastalarda Kanama ile İlişkili Faktörler

İskender AKSOY
Hızır Ufuk AKDEMİR
Mehmet EKİZ
Latif DURAN
Pages
482–491
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, the factors affecting the bleeding complications resulting from the use of warfarin were investigated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The most serious side effect of warfarin, an oral anticoagulant widely prescribed by many different disciplines, is bleeding.
📊
Key Findings & Data:Objective: The most serious side effect of warfarin, an oral anticoagulant widely prescribed by many different disciplines, is bleeding.
💡
Conclusion & Impact:In this study, the factors affecting the bleeding complications resulting from the use of warfarin were investigated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:varfarin · kanama · acil

Abstract

Objective: The most serious side effect of warfarin, an oral anticoagulant widely prescribed by many different disciplines, is bleeding. In this study, the factors affecting the bleeding complications resulting from the use of warfarin were investigated.

Özet

Amaç: Pek çok farklı disiplin tarafından yaygın olarak reçete edilen ve oral bir antikoagülan olan varfarinin en ciddi yan etkisi kanamadır. Bu çalışmada, varfarin kullanımı sonucu ortaya çıkan kanama komplikasyonu üzerine etkili olan faktörler araştırılmıştır.

🔖

Cite This Article

AKSOY, İ., AKDEMİR, H. U., EKİZ, M., DURAN, L. (2022). THE FACTORS ASSOCIATED WITH BLEEDING IN PATIENTS USING WARFARIN. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 3, 482–491. https://ajindex.com/articles/573303

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Stricker BHC. The risk of over anticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol. 2004;127(1):85-9
  2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):160S-98S
  3. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):110S-2S
  4. Makris M, Watson H. The management of coumarin‐induced over‐anticoagulation: Annotation. Br J Haematol. 2001;114(2):271-80
  5. Hollowell J, Ruigómez A, Johansson S, Wallander M-A, García-Rodríguez LA. The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract. 2003;53(489):312-4
  6. McMahan DA, Smith DM, Carey MA, Zhou XH. Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med. 1998;13(5):311-6
  7. Landefeld CS, Goldman OL. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87(2):144-52
  8. Wallvik J, Själander A, Johansson L, Bjuhr Ö, Jansson J-H. Bleeding complications during warfarin treatment in primary healthcare centers compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25(2):123-8
  9. Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ. Major bleeding complications in a specialized anticoagulation service. Am J Cardiol. 2005;96(4):595-8
  10. Koo S, Kucher N, Nguyen PL, Fanikos J, Marks PW, Goldhaber SZ. The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med. 2004;164(14):1557-60
  11. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial. Ann Intern Med. 2000;133(9):687-95
  12. Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130(5):1390-6
  13. Quirke W, Cahill MR, Perera K, Sargent J, Conway J. Warfarin prevalence, indications for use and haemorrhagic events. Ir Me